Kamdem-Ouaffo v. Pepsico Inc. et al
Filing
50
OPINION & ORDER: Defendants' Motion To Dismiss is granted. Plaintiff's First Amended Complaint is dismissed without prejudice. Plaintiff may file a Second Amended Complaint within thirty days that specifically addresses the deficiencie s identified in this Opinion. Also, Plaintiff may renew his request to join Scentsational Technologies LLC and Steven M. Landau and file claims against them. The Clerk of the Court is respectfully requested to terminate the pending Motion (Dkt. No. 34). SO ORDERED. (Signed by Judge Kenneth M. Karas on 3/9/2015) (lnl)
UNITED STATES DISTRICT COURT
SOUTHERN DISTRICT OF NEW YORK
RICKY KAMDEM-OUAFFO,
Plaintiff,
Case No. 14-CV-227 (KMK)
v.
OPINION & ORDER
PEPSICO, INC., DR. PETER S. GIVEN, JR.,
DR. NAIJIE ZHANG, JOHN DOE, and/or
JANE DOE,
Defendants.
Appearances:
Ricky Kamdem-Ouaffo
New Brunswick, NJ
Pro se Plaintiff
Robert Lawrence Maier
Jennifer Cozeolino Tempesta
Richard Benjamin Harper
Baker Botts LLP
New York, NY
Counsel for Defendants
KENNETH M. KARAS, District Judge:
Pro se Plaintiff Ricky Kamdem-Ouaffo (“Plaintiff”) filed this Action in January 2013
against Defendants Pepsico, Inc. (“PepsiCo”), Dr. Peter S. Given, Jr. (“Dr. Given”), Dr. Naijie
Zhang (“Dr. Zhang”), John Doe, and/or Jane Doe in January 2013. (Dkt. No. 1). Plaintiff
alleges several causes of action arising out of his employment at PepsiCo, arguing principally
that PepsiCo employees fraudulently commandeered his intellectual property. Before the Court
is Defendants’ Motion to Dismiss Plaintiff’s First Amended Complaint. For the foregoing
reasons, Defendants’ Motion is granted, and Plaintiff’s First Amended Complaint is dismissed.
I. BACKGROUND
A. Factual Background1
Plaintiff, a resident of New Brunswick, New Jersey, has “professional experience” in the
“research and development, manufacturing, analysis[,] and application of flavors and aromas,” as
well as “flavor encapsulation[] and the use applications of edible film formers.” (Pl.’s Mem. of
Law in Supp. of Pl.’s Countercl. and in Supp. of Denial of Defs.’ Mot. To Dismiss (“Pl.’s
Opp’n”) Ex. 1 (“SAC”) ¶¶ 1, 3–4 (Dkt. No. 43) (Plaintiff’s proposed Second Amended
Complaint).) From July 14, 2008 to September 28, 2009, Plaintiff worked as a “Food Scientist
contractor at PepsiCo’s Research and Development facility in Valhalla, New York.” (Id. ¶ 22.)
In that capacity, Plaintiff was tasked with “provid[ing] leadership and strategy for developing
[and] evaluating commercially viable Aroma Technology Delivery System[s] applicable to
PepsiCo’s commercial items.” (Id. ¶ 27.)
Prior to starting with PepsiCo, Plaintiff was required to sign a “Staffing Supplier
Employee Agreement Regarding Confidentiality and Intellectual Property” (“Agreement”) “with
Pepsico through Subex Technologies, Inc.” (“Subex”), the “contract [s]taffing [a]gency.” (Id.
¶ 23.) Plaintiff signed the Agreement on July 8, 2008, at which time a Subex manager
“explained to . . . Plaintiff . . . that the [A]greement . . . meant that . . . Plaintiff in principle
consented to assigning his future intellectual property to PepsiCo for commercial use in
The factual allegations that follow are derived from Plaintiff’s proposed Second
Amended Complaint (Dkt. No. 43), as discussed below. While the Court will sometimes refer to
Plaintiff’s contentions as “alleged,” the Court treats them as true for purposes of the instant
Motion.
This section omits facts and allegations that pertain to ScentSational Technologies LLC,
Steven M. Landau, and/or their pending lawsuit against PepsiCo, see Scentsational Techs., LLC,
No. 13-CV-8645 (S.D.N.Y. filed Dec. 5, 2013), because, Plaintiff’s request that they be joined as
necessary parties notwithstanding, (see, e.g., SAC ¶ 123), neither has been joined as a party in
this Action as of the date of this Opinion.
1
2
exchange for payment to be made to . . . Plaintiff during the course of the contract.” (Id. ¶¶ 23–
24.) At the same time, Plaintiff alleges that there was a “common understanding” that if Plaintiff
created intellectual property during the period of his contract that was patentable, “PepsiCo
would . . . credit . . . Plaintiff” as the inventor. (Id. ¶ 25.)
During the period of Plaintiff’s employment, Plaintiff “pioneered, conceptualized,
designed, demonstrated, proved, executed, and implemented aroma concepts, technologies, and
techniques . . . that none of [PepsiCo’s] employees [had] been able to do prior to Plaintiff’s
work.” (Id. ¶ 29.) Plaintiff also “filled up five to seven [l]aboratory [n]otebooks,” and created
“scientific reports and . . . computer data” pertaining to his inventions. (Id. ¶ 85.) Plaintiff
received $82,142 in compensation for his work, or $56,384 in take-home pay, which amounted
to only a percentage of the $133,007.50 Plaintiff alleges he is owed under an unsigned purchase
order (“Purchase Order”). (Id. ¶¶ 52–53, 186–87.)2
At some point prior to or on September 16, 2009, Defendants, at the direction of
PepsiCo senior managers, “removed . . . Plaintiff’s name from” intellectual property Plaintiff
created during his period of employment at PepsiCo. (Id. ¶¶ 32, 34.) In subsequent patent
applications, PepsiCo credited the inventions to Dr. Given and Dr. Zhang, despite the fact that
they allegedly did not “contribute to the creation” of that property. (Id. ¶ 32.) Plaintiff alleges
that Dr. Zhang was not an employee of PepsiCo when Plaintiff “created and conceptualized his
2
Plaintiff alleges that he received only 42.39% of the amount he alleges he is owed under
the Purchase Order, but by the Court’s calculation, Plaintiff received 61.76%, as Plaintiff does
not allege that the Purchase Order indicated that Plaintiff was to receive $133,007.50 after taxes.
(SAC ¶ 53.) Nonetheless, Plaintiff alleges that he is the owner of the remaining percentage of
his intellectual property. (Id.)
3
inventions and reduced them to practice,” and that Dr. Given provided “no intellectual input or
supervision” during that time. (Id. ¶ 33.)
Plaintiff further alleges that the removal of his name from his inventions was part of a
coordinated attempt by PepsiCo to distance itself from Plaintiff. On the same day that PepsiCo
managers removed Plaintiff’s name, Dr. Given allegedly sent an email to his colleagues which
said: “‘Another hitch – [Plaintiff’s] contract is terminating Oct. 5, and he’ll be informed this
week . . . more drama! Please do not distribute this info, but [it] may impact our decision on
inventorship.’” (Id. ¶ 8 (second alteration in original) (italics omitted).)3 Dr. Zhang allegedly
sent a similar email, stating that “‘Ricky Kamdem is not [the] inventor. He is just involved in the
project . . . .’” (Id. ¶ 9 (second alteration in original) (italics omitted).) PepsiCo’s Vice President
of Research and Development, Valerie Jacklin, allegedly wrote to Dr. Given and the Director of
the Ingredient Technology group, echoing Dr. Zhang’s sentiment when noting that she was
“‘[n]ot [s]ure [they] [w]ant [Plaintiff] [o]n [t]he [i]nvention [l]ist.’” (Id. ¶ 255 (italics omitted).)
An unnamed PepsiCo employee also allegedly entered a notation in Plaintiff’s personnel file
reading “Dept. not satisfied,” suggesting Plaintiff’s work was unsatisfactory. (Id. ¶ 38 (italics
omitted).)
On or around September 23, 2009, five days before the expiration of Plaintiff’s contract,
Plaintiff alleges that he was told by an unnamed human resources manager that he was
“‘culturally unfit’” for employment because he was “a black male [with] an opinion on scientific
matters that was contrary to that of his peers of [another] skin color,” and that he “needed to be
As outlined below, Plaintiff’s contract was scheduled to terminate on September 28,
rather than on October 5. (See id. ¶¶ 35–36.)
3
4
coached.” (Id. ¶ 64–66.)4 Plaintiff likewise alleges that PepsiCo’s decision not to credit Plaintiff
for his alleged inventions stemmed from “stereotypes and racial clichés about . . . Plaintiff as a
person of . . . black skin.” (Id. ¶ 257.) A few months later, on December 18, 2009, Plaintiff
alleges that Defendants wrote in a “Statement of Position” made to a United States government
agency that “Plaintiff was not able to do work, and was not creative . . . by comparison to [his]
counter parts [sic] of . . . other . . . race[s].” (Id. ¶¶ 67, 257.) Plaintiff claims that Defendants
“represent[ed] that . . . Plaintiff went to work only to look for opportunities for predatory sexual
intercourse activity on women.” (Id. ¶ 258; see also id. ¶ 68.)
On September 28, 2009, Plaintiff’s employment contract ended and was not renewed.
(Id. ¶¶ 35–36.)5 At the expiration of his contract, Plaintiff sent a letter to PepsiCo management
in which he made an “‘authorship claim on any current or future work resulting in . . . flavor
encapsulates or . . . aroma delivery systems because [he] single-handedly demonstrated the need
for [them] when no one at PepsiCo had [them] in mind . . . .” (Id. ¶ 62 (first and second
alterations in original) (italics omitted).) Thereafter, PepsiCo filed for five patents with the
United States Patent and Trademark Office (“USPTO”) based on the intellectual property at
issue, one of which, a patent application for “Releasable Entrapment of Aroma Using Polymeric
Matrix,” was granted on July 2, 2013 (US Patent No. 8,474,637 B2). (See id. ¶¶ 41, 47, 60.)6 In
4
Plaintiff does not specify whether the human resources manager was employed by
PepsiCo or Subex.
Plaintiff alleges that his contract was allowed to expire “for no reason other than to
seize the Plaintiff’s intellectual property.” (SAC ¶ 116.) However, as outlined above, Plaintiff
suggests that there may have been a race-based motive, and Plaintiff also implies in his Affidavit
that his contract was allowed to expire because of his criticism of the use of “formaldehyde
aroma capsules.” (Pl.’s Aff. ¶¶ 63–68, 71 (Dkt. No. 42).)
5
The other patent applications are as follows: one for “Releasably Encapsulated Aroma”
(US Patent App. No. US 13/56,551 A1), one for “Complex Coacervates and Aqueous Dispersion
6
5
connection with the patent applications, Dr. Given and Dr. Zhang allegedly each signed or
cosigned “Inventor’s Oath[s] or Declaration[s],” including a “Joint Inventor’s Declaration,” for
the granted patent. (Id. ¶¶ 44–48.) Dr. Given and Dr. Zhang each also allegedly executed and
filed an assignment of the relevant intellectual property to PepsiCo. (Id. ¶¶ 49–50.)
On October 11, 2012, Plaintiff submitted a request to PepsiCo, asking that it amend the
patent applications at issue “from which [it] . . . expunged . . . Plaintiff’s name” to include his
name. (Id. ¶ 55.) PepsiCo did not reply to this request, nor did it make the desired amendment.
(Id. ¶ 59.)7 Nonetheless, Plaintiff alleges that he is the “true inventor” of both the patented
property and the property described in the four pending patent applications. (Id. ¶¶ 60, 91, 106.)
B. Procedural History
Plaintiff filed the instant Action on January 31, 2014. (Dkt. No. 1.) On March 14, 2014,
the same day that Defendants first requested a pre-motion conference, (Dkt. No. 8), Plaintiff filed
his First Amended Complaint, alleging thirteen causes of action, namely “breach of intellectual
property agreement,” “wrongful appropriation of plaintiff’s intellectual property,” “fraudulent
obtaining of signature,” “correction of inventorship,” “unjust enrichment,” “the necessity of
constructive trusts,” a “request for subpoenas,” three causes of action relating to alleged false
statements made to the USPTO, and three causes of actions relating to other alleged criminal
conduct. (See Dkt. No. 9.) On March 26, 2014, Defendants filed two letters requesting a premotion conference. (Dkt Nos. 19, 20.) The Court granted Defendants’ request, (Dkt. No. 21),
of Complex Coacervates and Methods of [M]aking Same” (US Patent App. No. 13/272,270), and
two for “Coacervates Complex, Methods [a]nd Food [P]roducts” (US Patent App. Nos.
13/175,508 and 13/175,451). (SAC ¶¶ 48, 60.)
7
Plaintiff alleges that he also contacted the Westchester County District Attorney and the
FBI about this matter. (See Pl.’s Aff. ¶¶ 95–98.)
6
and at the pre-motion conference held on May 15, 2014, the Court set a briefing schedule for
Defendants’ Motion to Dismiss, (see Dkt. (minute entry for May 15, 2014)). Defendants filed
their Motion To Dismiss and Memorandum of Law on June 6, 2014, (Dkt. Nos. 34, 35), and an
associated Declaration on June 9, 2014, (Dkt. No. 37). On July 9, 2014, Plaintiff submitted a
“Notice of Counterclaim . . . in Support of the Denial of the Defendants’ Motion to Dismiss,”
and an Affidavit and Memorandum of Law in support of that submission. (Dkt. Nos. 41, 42,
43.)8 Plaintiff also filed a “Proposed Order [G]ranting . . . Plaintiff’s Counterclaim” on July 10,
2014. (Dkt. No. 44.) Defendants filed their Reply on August 8, 2014. (Dkt. No. 46.)
Plaintiff has also filed a number of letters and requests, particularly during the two-month
period preceding the pre-motion conference on Defendants’ Motion To Dismiss. On March 18,
2014, Plaintiff filed a letter in response to Defendants’ requests for a pre-motion conference,
contesting Defendants’ claims and requesting that the Court “allow the [j]udicial process to
continue its normal course to the next step of discovery.” (Dkt. No. 14 at 10). On March 21,
2014, Plaintiff filed a letter identifying alleged inaccuracies on the docket. (See Dkt. No. 16.)
On March 24, 2014, Plaintiff filed a letter requesting permission to join ScentSational
Technologies LLC and Steven M. Landau as co-defendants. (See Dkt. No. 18.) On March 27,
2014, Plaintiff filed a “Supplemental Answer” to Defendants’ requests for a pre-motion
conference, making similar arguments to those in his March 18 letter, (see Dkt. No. 22), and to
which Defendants replied on April 3, 2014, (Dkt. No. 25). On March 31, 2014, Plaintiff filed a
letter seeking to introduce “[a]ccusatory [e]vidence” for the arrest of Defendants Dr. Given and
Dr. Zhang. (Dkt. No. 24 at 1.) On April 7, 2014, Plaintiff filed a letter requesting that the Court
8
Plaintiff requested permission to file his Affidavit on July 2, 2014, (see Dkt. No. 39),
which the Court granted, (see Dkt. No. 40).
7
assign a magistrate judge to adjudicate Plaintiff’s criminal allegations. (See Dkt. No. 26.) On
April 14, 2014, Plaintiff filed a letter contending that Defendants could not make any res judicata
arguments in connection with a related case pending in New York Supreme Court. (See Dkt. No.
28.) 9 Plaintiff made additional arguments in support of this claim in a letter filed on April 16,
2014. (See Dkt. No. 29.) On April 24, 2014, Plaintiff filed what he termed his “Pre-Motion
Conference Concluding Remarks” three weeks before the pre-motion conference was held. (Dkt.
No. 30.) Later, on August 14, 2014, after Defendants’ Motion To Dismiss was fully briefed,
Plaintiff filed a letter containing proposed talking points for oral argument on his Counterclaim.
(See Dkt. No. 47.) Finally, in late November 2014, Plaintiff sent a letter to the Court disclosing
9
In September 2010, Plaintiff filed a similar lawsuit in New York Supreme Court,
Westchester County. See Kamdem-Ouaffo v. PepsiCo, Inc., No. 22625/2010 (N.Y. Sup. Ct.
2010). (See also Mem. of Law in Supp. of Defs.’ Motion To Dismiss 5 (Dkt. No. 34)
(acknowledging lawsuit).) Defendants assert that while the court in that case granted judgment
in Defendants’ favor on July 8, 2013, “a defense based on res judicata may be premature because
the judgment in [that] action is not yet final” due to a pending appeal. (Id. at 10 n.6 (italics
omitted); see also Decl. of Jennifer C. Tempesta in Supp. of Defs.’ Mot. To Dismiss Ex. 3, at 40
(Dkt. No. 37) (N.Y. Supreme Court decision granting summary judgment); Dkt. for KamdemOuaffo v. PepsiCo, Inc., No. 22625/2010 (N.Y. Sup. Ct. 2010) (noting that judgment for
Defendants was granted).) While the Court’s Opinion here does not rest on res judicata grounds,
it is worth noting that lower court orders have res judicata effect when they are issued, regardless
of whether they are appealed. See Arnold v. Beth Abraham Health Servs., Inc., No. 09-CV-6049,
2009 WL 5171736 , at *4 (S.D.N.Y. Dec. 30, 2009) (“Under New York law, the pendency of an
appeal does not deprive a challenged judgment of preclusive effect.”), aff’d on other grounds sub
nom. Arnold v. 1199 SEIU, 420 F. App’x 48 (2d Cir. 2011); In re Parmalat Sec. Litig., 493 F.
Supp. 2d 723, 737 (S.D.N.Y. 2007) (“Courts long have held that the pendency of an appeal
ordinarily does not suspend the preclusive effect of an otherwise final judgment.”), aff'd sub
nom. Bondi v. Capital & Fin. Asset Mgmt. S.A., 535 F.3d 87 (2d Cir. 2008); Aaron v. Aaron, 768
N.Y.S.2d 739, 741 (App. Div. 2003) (“[A]bsent a stay, the pendency of an appeal from [a]
judgment does not alter the finality or enforceability of that judgment.”); cf. DiSorbo v. Hoy, 343
F.3d 172, 183 (2d Cir. 2003) (“Under New York law, the mere pendency of an appeal does not
prevent the use of the challenged judgment as the basis of collaterally estopping a party to that
judgment in a second proceeding.” (internal quotation marks omitted)).
8
the name of an FBI investigator allegedly assigned to his case; the Court docketed a redacted
version of this letter on December 1, 2014. (See Dkt. No. 48.)
Together with the Memorandum of Law that Plaintiff submitted in response to
Defendants’ Motion To Dismiss, Plaintiff included a proposed Second Amended Complaint.
(See SAC.) While the conduct Plaintiff alleges in his Second Amended Complaint is almost
entirely identical to that in Plaintiff’s First Amended Complaint, a few differences are worth
noting. First, Plaintiff added ScentSational Technologies LLC and Steven M. Landau as
Defendants—two parties Plaintiff previously requested permission to join—and included
allegations against them. (See id.) Second, Plaintiff withdrew his second, third, and sixth causes
of action, which pertained to false statements allegedly made to the USPTO, and his fourth, fifth,
and ninth causes of action, which pertained to alleged criminal conduct, instead requesting the
“[i]nitiation [o]f [a] [s]eparate [c]riminal [c]omplaint [a]gainst . . . Defendants” PepsiCo, Dr.
Zhang, and Dr. Given. (See id. at 25–26, 28.)10 Third, Plaintiff withdrew his thirteenth cause of
action, his request for subpoenas, and instead requested joinder of ScentSational Technologies
LLC and Steven M. Landau. (See id. at 32.) Fourth, Plaintiff added fifteen new causes of action,
including a number of claims based on the New York Uniform Commercial Code. (Id. at 32–
49.)
Defendants reviewed and responded to Plaintiff’s proposed Second Amended Complaint
in their Reply. (Defs.’ Reply Mem. of Law in Further Supp. of Defs.’ Mot. To Dismiss (“Defs.’
Reply”) 8–10 (Dkt. No. 46).) Therefore, without accepting the proposed Second Amended
10
Claim numbers in this Opinion are the numbers Plaintiff assigned them in his proposed
Second Amended Complaint.
9
Complaint for filing, the Court will consider the allegations and claims contained in the proposed
Second Amended Complaint together with those contained in First Amended Complaint.11
II. DISCUSSION
A. Standard of Review
To survive a motion to dismiss under Rule 12(b)(6), “a complaint must allege sufficient
facts which, taken as true, state a plausible claim for relief.” Keiler v. Harlequin Enters. Ltd.,
751 F.3d 64, 68 (2d Cir. 2014). In reviewing a complaint, the Court “accept[s] all factual
allegations as true and draw[s] every reasonable inference from those facts in the plaintiff’s
favor.” In re Adderall XR Antitrust Litig., 754 F.3d 128, 133 (2d Cir. 2014) (internal quotation
marks omitted). Moreover, along with the Complaint itself, the Court “may consider . . . any
written instrument attached to the complaint as an exhibit, any statements or documents
incorporated in it by reference, and any document upon which the complaint heavily relies.”
The Court notes that “[i]t is within [its] discretion to deny leave to amend implicitly by
not addressing the request when leave is requested informally in a brief filed in opposition to a
motion to dismiss.” In re Tamoxifen Citrate Antitrust Litig., 466 F.3d 187, 220 (2d Cir. 2006),
abrogated on other grounds by F.T.C. v. Actavis, Inc., 133 S. Ct. 2223 (2013). Indeed,
Defendants argue that Plaintiff may not amend his pleadings in his brief at all. (Defs.’ Reply 8
(citing Jacobson v. Peat, Marwick, Mitchell & Co, 445 F. Supp. 518, 526 (S.D.N.Y. 1977)).)
However, where new allegations in a pro se plaintiff’s responsive memoranda “are consistent
with the allegations contained” in the complaint, they may be read “as supplements to th[e]
pleadings.” Boyer v. Channel 13, Inc., Nos. 04-CV-2137, et al., 2005 WL 2249782, at *6
(S.D.N.Y. Mar. 9, 2005); see also Paul v. Bailey, No. 09-CV-5784, 2013 WL 2896990, at *5
(S.D.N.Y. June 13, 2013) (considering “factual allegations made by [the] pro se [p]laintiff in [the
plaintiff’s] opposition papers” because they were “consistent with those in the initial complaint
and amended complaints” (italics omitted)); Gertskis v. U.S. E.E.O.C., No. 11-CV-5830, 2013
WL 1148924, at *1 (S.D.N.Y. Mar. 20, 2013) (considering allegations from the plaintiff’s
opposition memoranda “to the extent they are consistent with the [a]mended [c]omplaint”), aff’d
sub nom. Gertskis v. E.E.O.C., — F. App’x —, 2014 WL 6865499 (2d Cir. Dec. 8, 2014);
Chukwueze v. NYCERS, 891 F. Supp. 2d 443, 448 (S.D.N.Y. 2012) (“[B]ecause a pro se
plaintiff’s allegations must be construed liberally[,] it is appropriate for a court to consider
factual allegations made in a pro se plaintiff’s opposition memorandum, as long as the
allegations are consistent with the complaint.” (italics omitted)). It is this approach that the
Court adopts here.
11
10
ASARCO LLC v. Goodwin, 756 F.3d 191, 198 (2d Cir. 2014) (internal quotation marks omitted),
cert. denied, 135 S. Ct. 715 (2014).
The Supreme Court has held that “[w]hile a complaint attacked by a Rule 12(b)(6)
motion to dismiss does not need detailed factual allegations, a plaintiff’s obligation to provide
the ‘grounds’ of his [or her] ‘entitle[ment] to relief’ requires more than labels and conclusions,
and a formulaic recitation of the elements of a cause of action will not do.” Bell Atl. Corp. v.
Twombly, 550 U.S. 544, 555 (2007) (third alteration in original) (citations omitted). Instead, the
Supreme Court has emphasized that the “[f]actual allegations must be enough to raise a right to
relief above the speculative level,” id., and that “once a claim has been stated adequately, it may
be supported by showing any set of facts consistent with the allegations in the complaint,” id. at
563. A plaintiff must allege “only enough facts to state a claim to relief that is plausible on its
face.” Id. at 570. But if a plaintiff has “not nudged [his or her] claims across the line from
conceivable to plausible, the[] complaint must be dismissed.” Id.; see also Ashcroft v. Iqbal, 556
U.S. 662, 679 (2009) (“Determining whether a complaint states a plausible claim for relief
will . . . be a context-specific task that requires the reviewing court to draw on its judicial
experience and common sense. But where the well-pleaded facts do not permit the court to infer
more than the mere possibility of misconduct, the complaint has alleged—but it has not
‘show[n]’—‘that the pleader is entitled to relief.’” (alteration in original) (citation omitted)
(quoting Fed. R. Civ. P. 8(a)(2))). Where, as here, a complaint was filed pro se, it must be
construed liberally with “special solicitude” and interpreted to raise the strongest claims that it
suggests. Hill v. Curcione, 657 F.3d 116, 122 (2d Cir. 2011) (internal quotation marks omitted).
11
B. Analysis
Plaintiff’s claims, in large part, turn on the validity and meaning of the Agreement,
particularly the provisions concerning (a) with whom Plaintiff formed an employer-employee
relationship, and (b) the assignment of Plaintiff’s intellectual property rights. Not unexpectedly,
nearly the entirety of Defendants’ Motion is therefore based on assertions about one, or both, of
these provisions. (See Defs.’ Mem. of Law in Supp. of Defs.’ Mot. To Dismiss (“Defs.’ Mem.”)
6–10, 12–13, 14–16 (Dkt. No. 34.) The Court will therefore begin its analysis by evaluating the
relevant provisions of the Agreement, and the claims based on the interpretation of these
provisions.
1. Dismissal of Plaintiff’s Withdrawn Claims
The Court, as an initial matter, dismisses a number of Plaintiff’s claims. First, Plaintiff’s
second, third, and sixth causes of action, relating to false statements allegedly made to the
USPTO, are dismissed because Plaintiff has voluntarily withdrawn them, (see Pl.’s Opp’n 12
(“The Plaintiff has conceded that criminal allegations for the offenses committed by Defendants
at the United States Patent Office should be dismissed into a separate criminal proceeding.”); see
also SAC 25–26), and because no private right of action lies to correct false statements made to
the USPTO under 35 U.S.C. § 115, the statute Plaintiff cites in support of his second and third
claims, (see First Am. Compl. 26 (Dkt. No. 9)). See also Wise v. Hubbard, 769 F.2d 1, 3 (1st
Cir. 1985) (noting that § 115 “creates no duty between the patent applicant and the purported
inventor. Instead, because the [USPTO’s] interest is in rewarding the true inventor with the
issuance of a letter patent, the sole duty created is between the applicant and the Office.”);
Newberg v. Schweiss, No. 08-CV-4681, 2009 WL 3202380, at *6 (D. Minn. Sept. 30, 2009)
(“Under 35 U.S.C. § 115, . . . . [t]he duty to disclose all inventors . . . is a duty owed to the
12
USPTO, not to potential co-inventors. Indeed, breach of that statutory duty merely results in the
patent being ‘unauthorized by law and void.’” (quoting Wise, 769 F.2d at 3)). Second, Plaintiff’s
fourth, fifth, and ninth claims, relating to alleged criminal conduct, are dismissed because
Plaintiff has voluntarily withdrawn them, (see SAC 26, 28), and because “crimes . . . do not give
rise to civil causes of action,” Luckett v. Bure, 290 F.3d 493, 497 (2d Cir. 2002). The Court
likewise declines to grant Plaintiff leave to file a separate criminal complaint containing these
dismissed claims because “the law is well settled that no private citizen has a constitutional right
to bring a criminal complaint against another individual.” Lewis v. Gallivan, 315 F. Supp. 2d
313, 316 (W.D.N.Y. 2004); see also Linda R.S. v. Richard D., 410 U.S. 614, 619 (1973) (“[A]
private citizen lacks a judicially cognizable interest in the prosecution or nonprosecution of
another.”). Third and finally, Plaintiff’s thirteenth cause of action, relating to a request for
subpoenas, is dismissed because Plaintiff voluntarily withdrew this claim, (see SAC 32), and
because subpoenas are a discovery tool such that a request for them does not constitute a cause
of action, see Fed. R. Civ. P. 45.
The Court declines to rule on Plaintiff’s request to join Defendants ScentSational
Technologies LLC and Steven M. Landau. The Court’s dismissal of Plaintiff’s First Amended
Complaint, however, as discussed below, is without prejudice to Plaintiff renewing his request to
join these Defendants or alleging additional claims against them.
2. Plaintiff’s Employer-Employee Relationship
The terms of Plaintiff’s employment are provided by Attachments B and C (collectively,
the “Attachments”) of the Agreement, (see SAC Ex. DMD III (“Attachments”) at unnumbered
13
1–3).12 Both Attachments appear to bear Plaintiff’s signature, (see id. at unnumbered 2–3; see
also Pl.’s Opp’n 4 (admitting Plaintiff signed Attachment B), and are governed by New York
law, (see Defs.’ Mem. 8 n.5 (“The [P]arties agree that New York law applies to the IP
agreement.”); see also Attachment B ¶ K (“THIS AGREEMENT SHALL BE GOVERNED BY
THE LAWS OF THE STATE OF NEW YORK . . . .”)). Attachment B, the “Staffing Supplier
Employee Agreement Regarding Confidentiality and Intellectual Property” characterizes the
payment Plaintiff was to receive as being made “by [the] employer, the Staffing Supplier,” and
specifically explains that “[t]his Agreement does not constitute a contract of employment
between [PepsiCo] and [the signatory].” (Attachment B at unnumbered 1, ¶ C.) Attachment C,
the “Acknowledgment of Temporary Work Assignment,” likewise includes a provision which
provides that Plaintiff “understand[s] that [he is] an employee of the Staffing Supplier and . . .
not an employee of PepsiCo[,]” and that “the Staffing Supplier, and not PepsiCo, is solely
responsible for paying [his] compensation and any other benefits that [he] may be entitled to as
an employee of Staffing Supplier.” (Attachment C ¶ 1.) Attachment C also provides that
Plaintiff “understand[s] that Staffing Supplier has assigned [him] to a temporary work
assignment at PepsiCo . . . . for a defined period of time, the length of which may be increased or
decreased.” (Id. ¶ 2)13
12
The first two pages of the exhibit contain Attachment B, while the third page contains
Attachment C. (See Attachments.) The Court will hereinafter cite the individual Attachments as
“Attachment B” and “Attachment C.”
13
The Court considers Attachments B and C of the Agreement, as well as the Purchase
Order, when evaluating Defendants’ Motion because they are attached to, and referenced in, the
proposed Second Amended Complaint. See Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551
U.S. 308, 322 (2007) (“[C]ourts must consider the complaint in its entirety, as well as other
sources courts ordinarily examine when ruling on Rule 12(b)(6) motions to dismiss, in particular,
documents incorporated into the complaint by reference . . . .”); ASARCO, 756 F.3d at 198
(noting that the Court “may consider . . . any written instrument attached to the complaint as an
14
On the basis of the plain language of the Agreement, Plaintiff’s breach of contract claim
(claim 1) is dismissed. See Homeward Residential, Inc. v. Sand Canyon Corp., 298 F.R.D. 116,
129 (S.D.N.Y. 2014) (“Where a contract’s language is clear and unambiguous, a court may
dismiss a breach of contract claim on a Rule 12(b)(6) motion to dismiss.”). It is hornbook law
that an entity must be a party to a contract for a claim of breach of that contract to lie, unless the
entity has assumed or been assigned the contract. See La Barte v. Seneca Res. Corp., 728
N.Y.S.2d 618, 620 (App. Div. 2001) (“[The] [p]laintiffs may not maintain a cause of action for
breach of contract against those parties with whom [he or she] [was] not in privity.”); see also
Excelled Sheepskin & Leather Coat Corp. v. Oregon Brewing Co., No. 12-CV-1416, 2014 WL
3874193, at *12 (S.D.N.Y Aug. 5, 2014) (dismissing breach of contract claim because plaintiff
failed to “establish the first element of [a] breach of contract claim, . . . the existence of a
contract between [the plaintiff] and [the defendant]”); Keywell L.L.C. v. Pavilion Building
Installation Sys., Ltd., 861 F. Supp. 2d 120, 128 (S.D.N.Y. Mar. 12, 2012) (“In New York,
privity is essential to a contract claim.” (footnote omitted)); Hotel Acquarius B.V. v. PRT Corp.,
No. 92-CV-4498, 1992 WL 391264, at *6 (S.D.N.Y. Dec. 22, 1992) (“[I]f an entity is not a party
to a contract, no valid breach of contract claim exists against that entity.”); Crabtree v. Tristar
Auto. Grp., Inc., 776 F. Supp. 155, 166 (S.D.N.Y. 1991) (“It is hornbook law that a nonsignatory to a contract cannot be named as a defendant in a breach of contract action unless it has
exhibit, any statements or documents incorporated in it by reference, and any document upon
which the complaint heavily relies” (internal quotation marks omitted)); Int’l Audiotext Network,
Inc. v. Am. Tel. & Tel. Co., 62 F.3d 69, 72 (2d Cir. 1995) (“The complaint is deemed to include
any written instrument attached to it as an exhibit or any statements or documents incorporated
in it by reference.” (alteration and internal quotation marks omitted)); see also Fed. R. Civ. P.
10(c) (“A copy of a written instrument that is an exhibit to a pleading is a part of the pleading for
all purposes.”).
15
thereafter assumed or been assigned the contract.”). Under the Agreement, Plaintiff was clearly
an employee of Subex, and not of PepsiCo.14 Plaintiff recognizes this fact in his submissions,
(Pl.’s Opp’n 21 (“Plaintiff has at no time alleged that he was a PepsiCo employee . . . .”)), and
acknowledges that Subex, and not PepsiCo, was responsible for his payment, (id. at 18 (noting
that “PepsiCo . . . had indeed willfully delegated duties to its business partner [Subex],” and that
“PepsiCo did not have to delegate payment for . . . Plaintiff’s IP to Subex”)). In fact, Plaintiff
included a 2008 W-2 as an exhibit to his proposed Second Amended Complaint which identifies
Subex, rather than PepsiCo, as Plaintiff’s employer. (See SAC Ex. DMD VI at unnumbered 1.)
Therefore, under the plain terms of the Agreement, PepsiCo cannot be liable for any breach of
contract under the Agreement, to which it was not a party.
Potentially in response to this issue, Plaintiff suggests that the “Purchase Order . . . issued
on July 13th, 2008” modified Attachment B by “defin[ing] the specific terms of the payment
for . . . Plaintiff’s [i]ntellectual [p]roperty and . . . confidentiality.” (Pl.’s Opp’n 7–8, 17.)15
Plaintiff alleges that the Purchase Order at issue “was updated until October 20th 2009 and
specifically identified the amount of money to be paid by . . . PepsiCo . . . to . . . Plaintiff
and . . . established that . . . Plaintiff had indeed delivered the [i]ntellectual property [at issue] to
Defendant,” (id. at 17), and that Defendants “breach[ed] and fail[ed] to perform according to the
14
In his Memorandum of Law, Plaintiff argues that the Agreement constituted a
“delegation” of payment. (Pl.’s Opp’n 18.) This argument is contradicted by the plain language
of the Agreement. (See, e.g., Attachment B ¶ C (“This Agreement does not constitute a contract
of employment between [PepsiCo] and [the signatory.”).) PepsiCo therefore had no
responsibilities to Plaintiff under the Agreement which it could delegate.
Plaintiff’s allegations regarding misconduct stemming from a “failure to produce . . .
the . . . Purchase Order,” (Pl.’s Opp’n 22), or other information relating to Plaintiff’s tenure at
PepsiCo, (see id. at 9), are premature because they pertain to discovery.
15
16
payment terms set forth in. . . [the] Purchase Order,” (id. at 7). In support of this claim, Plaintiff
cites § 3-119 of the New York Uniform Commercial Code, which provides that “‘[a]s between
the obligor and his immediate obligee or any transferee[,] the terms of an instrument may be
modified or affected by any other written agreement executed as a part of the same transaction.’”
(Pl.’s Opp’n 17 (italics omitted) (quoting N.Y. U.C.C. § 3-119).)
Contract modifications, like any contract, require offer, acceptance, and valid
consideration. See Estate of Anglin ex rel. Dwyer v. Estate of Kelley ex rel. Kelley, 705 N.Y.S.2d
769, 772 (App. Div. 2000) (“[A] change in an existing contract must have new consideration to
support it.” (internal quotation marks omitted)); Beacon Terminal Corp. v. Chemprene, Inc., 429
N.Y.S.2d 715, 718 (App. Div. 1980) (“Fundamental to the establishment of a contract
modification is proof of each element requisite to the formulation of a contract, including mutual
assent to its terms.”); see also AIU Ins. Co. v. TIG Ins. Co., 934 F. Supp. 2d 594, 602 (S.D.N.Y.
2013) (“A valid modification of a contract must satisfy all the criteria essential for a valid
original contract, including offer, acceptance, and consideration.” (alterations and internal
quotation marks omitted)), aff’d, 577 F. App’x 24 (2d Cir. 2014). Under this standard, the
Purchase Order does not constitute a valid modification of the Agreement for two reasons. First,
Plaintiff, by his own admission, was unaware of the Purchase Order until May 2012, meaning it
was impossible for him to have “accepted” any modifications of the Agreement contained
therein prior to the termination of his employment. (See Pl.’s Aff. ¶ 48 (Dkt. No. 42) (“Only
during depositions for the Supreme Court of the State of New York case . . . did the Plaintiff
come into knowledge of the Purchase Order [d]etails, in May 2012 . . . .”).) Second, the
modification was not supported by adequate consideration. Plaintiff’s obligations under the
Agreement—namely his employment and the assignment of his intellectual property—were the
17
same as those under the purported modified contract, and thus they could not have served as
consideration for the modification. See Tierney v. Capricorn Investors, L.P, 592 N.Y.S.2d 700,
703 (App. Div. 1993) (“Neither a promise to do that which the promisor is already bound to do,
nor the performance of an existing legal obligation constitutes valid consideration.”).
The Purchase Order may also be interpreted, however, not as a contract modification, but
rather as memorializing promises that were part of the Agreement itself, i.e., that Plaintiff would
remain the named inventor of certain intellectual property and that PepsiCo would pay him the
amount outlined in the Purchase Order. (See SAC ¶ 25 (referencing a “common understanding”
that PepsiCo would credit Plaintiff’s inventions to him); Pl.’s Aff. ¶ 27 (averring that
“[P]laintiff’s signature was given [on Attachment B] on the sole basis of the promises of
payment made to the Plaintiff both . . . verbal[ly] and in writing as embodied in the Purchase
Order”).) There are several fatal flaws with such an interpretation. First, as an initial matter, no
part of the Purchase Order suggests that Plaintiff was entitled to have his name remain on his
intellectual property. Second, the Agreement contains a clause in Attachment B which provides
that “[i]n the event that either [Plaintiff’s] employer or [Plaintiff] has previously executed an
agreement with [PepsiCo] relating to the work which [Plaintiff is] about to undertake, it is
understood and agreed that the terms and provision of this Agreement will supersede any terms
and conditions of such previously executed agreement.” (Attachment B ¶ D.) This term, on its
face, forecloses the applicability of any prior agreement that Plaintiff’s name would remain on
his inventions after their assignment, that he was PepsiCo’s employee, or that he would receive
certain compensation. Third, New York’s parol evidence rule provides that “evidence outside
the four corners of the document” is admissible to modify or contradict a written agreement
“only if a court finds an ambiguity in the contract.” Schron v. Troutman Sanders LLP, 986
18
N.E.2d 430, 436 (N.Y. 2013); see also Polygram Holding, Inc. v. Cafaro, 839 N.Y.S.2d 493, 493
(App. Div. 2007) (“Absent fraud or mutual mistake, the parol evidence rule precludes a party
from offering evidence to contradict or modify an unambiguous contract.”); Telemundo Grp.,
Inc. v. Alden Press, Inc., 580 N.Y.S.2d 999, 1000 (App. Div. 1992) (“Extrinsic or parol evidence
is admissible . . . where it would not modify or contradict the terms of the contract, but would
explain ambiguities in the contract.”(internal quotation marks omitted)). Because the Agreement
is unambiguous as to Plaintiff’s assignment of his intellectual property unconditionally, and as to
the fact that Subex, and not PepsiCo, is Plaintiff’s employer, parol evidence is not admissible to
suggest that PepsiCo promised that Plaintiff’s name would remain on his inventions, or that
PepsiCo owed him compensation as his employer.
Giving Plaintiff the benefit of the doubt, the Court could construe the Purchase Order as
explaining another otherwise ambiguous term in the contract, namely the reference in
Attachment B to “payment to [Plaintiff] by [his] employer, the Staffing Supplier,” such that the
parol evidence rule would not bar consideration of the Purchase Order. (Attachment B at
unnumbered 1).16 However, even if the Purchase Order is relevant to the terms of the
On its face, the Purchase Order identifies Subex as the “vendor,” while the notes
section indicates that Subex billed PepsiCo for Plaintiff’s work, suggesting that the Purchase
Order reflected an agreement between Subex and PepsiCo involving PepsiCo’s payment to
Subex for contract work, rather than an agreement with Plaintiff himself. (See Pl.’s Opp’n Ex.
DMD V (Purchase Order).)
The Court is also skeptical that PepsiCo would have agreed to pay a six-figure sum to
Plaintiff for his intellectual property, and then, instead of including such figure in the
employment agreement, only ambiguously mentioned such sum in an unsigned purchase order.
Indeed, the New York Court of Appeals rejected a similar claim (albeit on a motion for summary
judgment) that an employment contract contained an implied term that provided a $170,000
bonus, noting that the parties “would be expected to make reference to such a large sum of
money in the agreement with particularity.” Namad v. Salomon, Inc., 543 N.E.2d 722, 723 (N.Y.
1989). In any event, the Court rejects Plaintiff’s claim here on the grounds discussed above.
16
19
Agreement, it does not suggest that Plaintiff was entitled to the $133,007.50 he claims. Indeed,
the Purchase Order suggests that Plaintiff received hourly pay, rather than a fixed fee, and that
his pay rate was $40 per hour. (Pl.’s Opp’n Ex. DMD V (Purchase Order); see also id. Ex. DMD
II at unnumbered 4 (job description, indicating a “pay rate” of $40.00).) The $133,007.50 figure
that Plaintiff cites is labeled as a “PO Limit Total,” which reflects the combined total of two
separate pay limits in the Purchase Order for standard and overtime work of $118,800 and
$14,107.50, respectively. (Id. Ex. DMD V.) While Plaintiff argues, in his August 11, 2014 letter
to the Court, that “limit” in this case means a “lower limit,” that interpretation contradicts the
plain meaning and regular usage of such term. See Brooke Grp. Ltd. v. JCH Syndicate 488, 663
N.E.2d 635, 638 (N.Y. 1996) (“The words and phrases used by the parties must, as in all cases
involving contract interpretation, be given their plain meaning.”); Am. Express Bank Ltd. v.
Uniroyal, Inc., 562 N.Y.S.2d 613, 614 (App. Div. 1990) (“Words and phrases are given their
plain meaning. Rather than rewrite an unambiguous agreement, a court should enforce the plain
meaning of that agreement.” (citations omitted)); cf. Liberty Mut Ins. Co. v. N. Picco & Sons
Contracting Co., No. 05-CV-217, 2008 WL 190310, at *15 (S.D.N.Y. Jan. 16, 2008) (“Parties to
a contract may not create an ambiguity merely by urging conflicting interpretations of their
agreement.” (internal quotation marks omitted)). Had PepsiCo intended Plaintiff’s interpretation
of the contract, it would have used the word “minimum,” which implies a lower limit, rather than
“limit,” which implies a ceiling.17 Moreover, it strains reason to believe that PepsiCo would ever
The dictionary definition of “limit” is “[a] point or level beyond which something does
not or may not extend or pass.” Limit, Oxford Dictionaries,
http://www.oxforddictionaries.com/us/definition/american_english/limit (last accessed Jan. 6,
2015). Construing “limit” in the Purchase Order as an upper limit would set definite bounds,
consistent with this definition of the term, whereas interpreting the term as a minimum payment
“delimits” Plaintiff’s pay altogether, as any amount higher than the amount specified in the
Purchase Order would be permissible under the Agreement according to such an interpretation.
17
20
issue an unsigned purchase order for minimum compensation, never mind one that specifies an
hourly salary that a minimum compensation provision would render superfluous, especially
given that it is Subex, and not PepsiCo, which was required to pay Plaintiff. See Am. Express
Bank, 562 N.Y.S.2d at 614 (“A contract should be construed so as to give full meaning and
effect to all of its provisions.”). Therefore, the Court finds no support on the face of the
Purchase Order for Plaintiff’s contention that he is owed $133,007.50 under the Agreement, such
that payment of less than that amount would constitute a breach. Rather, the Purchase Order
provides, at most, a maximum amount that Plaintiff may receive under the Agreement.18
Plaintiff admits that he received $82,142, which amounted to $56,384 after taxes, as
compensation. (See SAC ¶ 52.) Though Plaintiff alleges that he received “[n]o other valuable
consideration,” (Pl.’s Opp’n 4), Plaintiff does not allege that he was deprived of “the use of
[PepsiCo’s] facilities or materials, or of private or proprietary information,” as promised in the
Agreement, (Attachment B at unnumbered 1). Plaintiff appears to suggest instead that he simply
received no other monetary compensation for his property. (See Pl.’s Aff. ¶¶ 35, 42 (citing W-2
statement as evidence that Plaintiff received no other compensation); id. ¶ 38 (noting that
Plaintiff “did not receive any additional income from any source”).) Therefore, there is no
reason to doubt that Plaintiff received the consideration that he was promised on the face of the
Agreement, or as suggested by the Purchase Order. On that basis, and because Plaintiff was an
18
Plaintiff fails to explain why he is entitled to an interest in the intellectual property he
transferred that is proportionate to the amount of compensation he alleges is owed. (See SAC
¶ 238). Even if Plaintiff could recover from Subex, because Plaintiff’s contract was with Subex
for the benefit of PepsiCo, rather than with PepsiCo itself, he is not entitled to restitution. Cf.
U.S. E. Telecomms. Inc. v. US W. Commc’ns Servs., Inc., 38 F.3d 1289, 1297 (2d Cir. 1994) (“A
person who has conferred a benefit upon another as the performance of a contract with a third
person is not entitled to restitution from the other merely because of the failure of the
performance of the third person.” (quoting Restatement of Restitution § 110 (1937)).)
21
employee of Subex, and not of PepsiCo, Plaintiff’s breach of contract claim against PepsiCo is
dismissed.
3. Intellectual Property Provision
For purposes of Plaintiff’s assignment of intellectual property, the pertinent portion of the
Agreement is Attachment B. Attachment B provides, in relevant part, that:
In consideration of payment to me by my employer, the Staffing Supplier . . . for
the performance of work or assignments for PepsiCo, Inc. . . . and other good and
valuable consideration, including the use on behalf of Company of its facilities or
materials, or of private or proprietary information owned by [PepsiCo] or its
suppliers or customers, I agree to the following provisions:
A. I hereby assign and agree to assign to [PepsiCo] all my right, title and interest
in and to all inventions, discoveries, improvements, ideas, products, formulae,
machines, mask works, designs, methodologies, processes, know-how,
research and development, software, source code, computer or other apparatus
programs and related documentation, and other works of authorship . . .
whether or not patentable, copyrightable or subject to other forms of
protection, made created, developed, written or conceived by me during the
period of such work or performance of assignments, whether during or outside
of regular working hours, either solely or jointly with another, in whole or in
part
1. In the course of such work assignment, or
2. Which are suggested by or result from any task assigned to me or work
performed for or on behalf of Company relating to my assignment, or
3. With the use of Company’s time, material, facilities, or private or
proprietary information;
B. I will . . . execute a specific assignment of title to Company and do anything
else reasonably necessary to enable company to secure a patent . . .
C. This Agreement does not . . . confer upon me any rights by license or
otherwise in my Intellectual Property to which I may have access . . .
D. The above terms shall survive termination, cancellation or expiration of this
Agreement and the work or assignments for which I was engaged . . .
K. THIS AGREEMENT SHALL BE GOVERNED BY THE LAWS OF THE
STATE OF NEW YORK . . . .
22
(Attachment B at unnumbered 1–2.) While the Agreement, as noted above, is governed by New
York law, the operation of the assignment of rights is governed by Federal Circuit law. See
Picture Patents LLC v. Aeropostale, Inc., 788 F. Supp. 2d 127, 135 (S.D.N.Y. 2011) (“[T]he
question of whether contractual language effects a present assignment of patent rights, or an
agreement to assign rights in the future, is resolved by Federal Circuit Law.” (internal quotation
marks omitted)), aff’d 469 F. App’x 912 (Fed. Cir. 2012).
On its face, Attachment B is a clear and explicit assignment of all intellectual property
from Plaintiff to PepsiCo. The “I hereby assign . . . my right title and interest” clause contained
in the Attachment B “indicate[s] a present assignment of a future invention,” meaning all of the
intellectual property that Plaintiff created during the period of his employment was automatically
transferred to PepsiCo as soon as it was invented. Id. at 135–36 (noting that “[t]he present
assignment of a future invention divests the inventor-assignor of ownership of the invention and
automatically vests ownership of the invention, when invested, to the assignee” (internal
quotation marks omitted)); see also Preston v. Marathon Oil Co., 684 F.3d 1276, 1288 (Fed. Cir.
2012) (“Because the assignment clause . . . states that the employee agrees to ‘hereby assign’ all
‘Intellectual Property,’ it is an express assignment of rights in future inventions that
automatically assigned rights . . . without the need for any additional act.”).
The fact that Plaintiff contractually transferred his intellectual property to PepsiCo
undermines a number of Plaintiff’s claims. The Court considers them in the order that Plaintiff
alleges them in his proposed Second Amended Complaint. First, in order to claim wrongful
appropriation of intellectual property (claims 7 and 24), Plaintiff “must establish some wrongful
appropriation or use of [his] intellectual property.” Dow Jones & Co. v. Int’l Sec. Exch., Inc.,
451 F.3d 295, 302 (2d Cir. 2006); see also Gross v. Bare Escentuals Beauty, Inc., 632 F. Supp.
23
2d 293, 297–98 (S.D.N.Y 2008) (citing Dow Jones for this proposition, and granting summary
judgment on the plaintiffs’ wrongful appropriation claim because they “failed to establish that
they have an intellectual property right that has been misappropriated”). While Plaintiff argues
that the Defendants are not “holders in due course of” the intellectual property at issue because
“the Purchase Order . . . has not been honored,” (SAC ¶ 228), as discussed above, the Purchase
Order is not a valid modification of the Agreement nor a contract in its own right, and does not
entitle Plaintiff to the compensation he alleges, create an employment agreement with PepsiCo,
or entitle Plaintiff to rescind the assignment of his intellectual property rights, which assignment
vested upon invention. Therefore, Plaintiff has no contractual or residual right to his inventions,
and his wrongful appropriation claims are dismissed. For the same reason, Plaintiff’s joint
owners claim (claim 25) is dismissed. Plaintiff does not retain an interest in his inventions “in
proportion to the [Purchase Order] proportion that the Defendant[s] did not honor” such that
Plaintiff is a joint owner or has any remaining interest in his inventions at all. (Id. ¶ 238.)
Second, Plaintiff makes two fraud-based claims, “fraudulent obtaining of signature”
(claim 8), and “fraudulent intent breach of agreement for assignment of intellectual property”
(claim 14). These claims, which allege that “[D]efendants used fraudulent means to take away
from him his intellectual property,” (Pl.’s Opp’n 7), are dismissed because Plaintiff fails to
allege, in either case, a cause of action upon which relief can be granted.
It long has been clear that “[a]llegations of fraud are subject to a heightened pleading
standard.” Nakahata v. N.Y.-Presbyterian Healthcare Sys., Inc., 723 F.3d 192, 197 (2d Cir.
2013); see also Fed. R. Civ. P. 9(b) (“In alleging fraud or mistake, a party must state with
particularity the circumstances constituting fraud or mistake.”). “When alleging fraud, a party
24
must state with particularity the circumstances constituting fraud, . . . requir[ing] the plaintiff to
(1) specify the statements that the plaintiff contends were fraudulent, (2) identify the speaker,
(3) state where and when the statements were made, and (4) explain why the statements were
fraudulent.” Nakahata, 723 F.3d at 197 (citation and internal quotation marks omitted). Plaintiff
fails to satisfy the fourth prong of the pleading standard because he does not specify any federal
or state law that Defendants have violated. Moreover, even if Plaintiff intended to allege
common law fraud under New York law, he fails to allege facts that establish the elements of a
common law fraud claim: “(1) a misrepresentation of material fact, (2) made with fraudulent
intent, (3) upon which the plaintiff reasonably relies to his (4) economic detriment.” Nirvana
Int’l., Inc. v. ADT Sec. Servs., Inc., 881 F. Supp. 2d 556, 563 (S.D.N.Y. 2012), aff’d, 525 F.
App’x 12 (2d Cir. 2013).
Plaintiff’s first fraud-based claim, “[f]raudulent [o]btaining [o]f [s]ignature” rests only on
the conclusory allegation that the signatures on PepsiCo’s patent applications were fraudulent
because Defendants “were not the inventors of the Plaintiff’s intellectual property.” (SAC
¶¶ 139–140.) Plaintiff does not explain how PepsiCo’s actions were fraudulent given that an
assignee of intellectual property is permitted to make a patent application. See 35 U.S.C. § 118
(“A person to whom the inventor has assigned . . . the invention may make an application for
patent.”); cf. id. § 115 (providing that an inventor’s declaration is only required for those
applications commenced “under section 111(a)” or those that “commence[] the national stage
under section 271”); Deere & Co. v. Van Natta, 660 F. Supp. 433, 436 (M.D.N.C. 1986) (noting
that, because the plaintiff could file a patent application as an assignee, there was no need to
order the defendant inventor to sign a declaration indicating there were no bars to the patent
applications at issue). Plaintiff also does not allege that he relied on any fraudulently-obtained
25
signature, cf. Nirvana Int’l, 881 F. Supp. 2d at 563 (“[The] [p]laintiff did not rely on his forged
signature so [the] [p]laintiff has no claim for fraud.”), nor does he explain why, given that
Plaintiff assigned his intellectual property rights to PepsiCo, any fraudulently-obtained signature
caused him economic harm.
Plaintiff’s second fraud-based claim, “[f]raudulent [i]ntent [b]reach [o]f [a]greement [f]or
[a]ssignment [o]f [i]ntellectual [p]roperty,” rests on the allegation that “[t]he order to
expunge . . . [P]laintiff’s name from his inventions” was improper. (SAC ¶ 169.) Like
Plaintiff’s first fraud claim, this claim also fails to include any allegations of reliance on a
misrepresentation of material fact or resulting economic detriment. Moreover, as discussed
above, even if the Parties had come to some “understanding” that Plaintiff was to remain a
named inventor, (see id. ¶ 25), Plaintiff does not allege that such understanding was a valid
contract modification, nor can an oral agreement provide additional terms under New York’s
parol evidence rule, given that the Agreement unambiguously indicates that Plaintiff agreed to
assign his intellectual property rights to PepsiCo without condition. See Schron, 986 N.E.2d at
433 (noting that New York’s parol evidence rule provides that “evidence outside the four corners
of the document” is admissible to alter or add a provision to a written agreement “only if a court
finds an ambiguity in the contract”). Plaintiff’s fraud claims are therefore dismissed.
Third, Plaintiff’s unjust enrichment claim (claim 11) is dismissed. Plaintiff alleges that
Defendants were “unjustly enriched through their wrongful appropriation of . . . Plaintiff’s
[i]ntellectual [p]roperty and have wrongfully secured for their own benefit valuable utility
patents of commercial value that PepsiCo’s competitors would be interested in using [in] the
market place.” (SAC ¶ 154.) While this claim appears to be a species of Plaintiff’s wrongful
appropriation claims, which the Court has already dismissed, the existence of a valid contract
26
also renders unjust enrichment unavailable as a remedy. See Clark-Fitzpatrick, Inc. v. Long
Island R.R. Co., 516 N.E.2d 190, 193 (N.Y. 1987) (“The existence of a valid and enforceable
written contract governing a particular subject matter ordinarily precludes recovery in quasi
contract for events arising out of the same subject matter.”); see also Arbitron, Inc. v. Kiefl, No.
09-CV-4013, 2010 WL 3239414, at *7 (S.D.N.Y. Aug. 13, 2010) (“Unjust enrichment is not
available where there is a valid contract between the parties covering the same subject matter.”);
AngioDynamics, Inc. v. Biolitec, Inc., 606 F. Supp. 2d 300, 305 (N.D.N.Y. 2009) (“Because the
dispute is covered by [a] contract, a claim in unjust enrichment cannot proceed.”); Am. Med.
Ass’n v. United Healthcare Corp., No. 00-CV-2800, 2007 WL 683974, at *10 (S.D.N.Y. Mar. 5,
2007) (“[D]ecisions both in New York state courts and in [the Southern District of New York]
have consistently held that claims for unjust enrichment may be precluded by the existence of a
contract governing the subject matter of the dispute . . . .”).
The Court recognizes that, under Federal Rule of Civil Procedure 8(d), a plaintiff can
plead in the alternative such that he can challenge the validity of the contract and allege unjust
enrichment. See Adler v. Pataki, 185 F.3d 35, 41 (2d Cir.1999) (“[Rule 8(d)] offers sufficient
latitude to construe separate allegations in a complaint as alternative theories, at least when
drawing all inferences in favor of the nonmoving party as we must do in reviewing orders
granting motions to dismiss.”). However, where a plaintiff, as here, fails to challenge the
validity of a contract that governs the subject matter at issue, and instead alleges breach of said
otherwise enforceable contract, under New York law he or she cannot plead unjust enrichment in
the alternative. See Beth Israel Med. Ctr. v. Horizon Blue Cross & Blue Shield of N.J., Inc., 448
F.3d 573, 586–87 (2d Cir. 2006) (noting that an unjust enrichment claim cannot be plead in the
alternative when there is a “valid and enforceable contract governing . . . [the] subject matter”);
27
King’s Choice Neckwear, Inc. v. Pitney Bowes, Inc., No. 09-CV-3980, 2009 WL 5033960, at *7
(S.D.N.Y. Dec. 23, 2009) (“Unjust enrichment may be plead in the alternative where the plaintiff
challenges the validity of the contract; it may not be plead in the alternative alongside a claim
that the defendant breached an enforceable contract.”), aff’d sub nom. Kings Choice Neckwear,
Inc. v. Pitney Bowes, Inc., 396 F. App’x 736 (2d Cir. 2010); see also Sikarevich Family L.P. v.
Nationwide Mut. Ins. Co., No. 13-CV-5564, 2014 WL 3127729, at *4 (E.D.N.Y. July 3, 2014)
(dismissing unjust enrichment claim, plead in the alternative with a breach of contract claim,
because the plaintiff did not challenge the insurance policy at issue); AngioDynamics, 606 F.
Supp. 2d at 305 (dismissing unjust enrichment counterclaim, plead in the alternative, “[b]ecause
the dispute [at issue] [was] covered by the [undisputed] contract, [meaning] a claim in unjust
enrichment [could not] proceed”); Air Atlanta Aero Eng’g Ltd. v. SP Aircraft Owner I, LLC, 637
F. Supp. 2d 185, 196 (S.D.N.Y. 2009) (dismissing unjust enrichment claim, plead in the
alternative, noting that “[Plaintiff’s] failure to allege that the contracts at issue are invalid or
unenforceable precludes it . . . from seeking quasi-contractual recovery for events arising out of
the same subject matter.”). But see St. John’s Univ., New York v. Bolton, 757 F. Supp. 2d 144,
184 (E.D.N.Y. 2010) (“Though some cases suggest that a plaintiff’s mere allegation of an
enforceable contract is enough to prevent him from even pleading an alternative claim for unjust
enrichment, that position cannot be reconciled with the text of Rule 8(d), and is unpersuasive to
this court’s analysis.” (footnote omitted)). Because Plaintiff does not challenge the validity of
the Agreement (its exact terms, as allegedly modified by the Purchase Order, notwithstanding),
and the Agreement governs Plaintiff’s rights to the intellectual property at issue, Plaintiff’s
unjust enrichment claim is dismissed.
28
Fourth, Plaintiff’s correction of inventorship claim (claim 10), made purportedly under
35 U.S.C. § 256 and presumably for the five patents (included the granted patent) Plaintiff
outlined in his Amended Complaint, is dismissed. (See SAC 28.) The Federal Circuit has made
clear that while 35 U.S.C. § 256 “provides a private right of action to challenge inventorship” for
issued patents, 35 U.S.C. § 116, which governs inventions, “does not provide a private right of
action to challenge inventorship of a pending patent application.” HIF Bio., Inc. v. Yung Shin
Pharm. Indus. Co., 600 F.3d 1347, 1354 (Fed. Cir. 2010). Thus, Plaintiff cannot bring a cause of
action for a correction of inventorship for the four pending patent applications. As far as
correction of inventorship for the single issued patent is concerned, while a private right of action
may exist, because Plaintiff assigned his intellectual property rights to PepsiCo, he lacks
standing to make such a claim. Plaintiff has no remaining ownership interest in the patents, and
he has alleged no other financial or reputational interest on which to base standing. See Larson
v. Correct Craft, Inc., 569 F.3d 1319, 1325–27 (Fed. Cir. 2009) (noting that for a plaintiff to
have standing to correct inventorship, the plaintiff must allege facts sufficient to show an
“ownership interest” or a “concrete financial interest” in the patent at issue, and finding no
standing for such claim because the plaintiff “affirmatively transferred title to the patents to
[defendant]” and thus could not stand to gain from them unless he “obtain[ed] rescission of the
patent assignments” (internal quotation marks omitted)); see also Vita-Herb Nutriceuticals, Inc.
v. Probiohealth, LLC, No. 11-CV-1463, 2013 WL 1182992, at *4 (C.D. Cal. Mar. 20, 2013)
(finding no standing for a correction of inventorship claim because the plaintiff was “barred by
the terms of [a release] from pursuing any claim for co-ownership” and thus lacked a financial
interest); Swanson v. ALZA Corp., No. 12-CV-4579, 2013 WL 968275, at *4 (N.D. Cal. Mar.
12, 2013) (“Where an inventor assigns all of his interest in an invention to others, he retains no
29
financial interest in the patents and therefore no interest sufficient for him to have standing to
pursue a § 256 claim.” (internal quotation marks omitted)). For these reasons, Plaintiff’s
correction of inventorship claim is dismissed.
Fifth, Plaintiff’s constructive trust claim (claim 12) is dismissed. “Under New York law,
the equitable remedy of a constructive trust is appropriate when there is clear and convincing
evidence of (1) a confidential or fiduciary relationship; (2) an express or implied promise; (3) a
transfer in reliance on such a promise; and (4) unjust enrichment.” Martha Graham Sch. &
Dance Found., Inc. v. Martha Graham Ctr. of Contemporary Dance, Inc., 380 F.3d 624, 646 (2d
Cir. 2004); see also Atateks Foreign Trade Ltd. v. Dente, 798 F. Supp. 2d 506, 507 (S.D.N.Y.
2011) (same); Sharp v. Kosmalski, 351 N.E.2d 721, 723 (N.Y. 1976) (same). However, “these
elements are not talismanic; a court may impose a constructive trust in the absence of some of
the factors.” A. Brod, Inc. v. SK&I Co., 998 F. Supp. 314, 327 (S.D.N.Y. 1998). In this context,
under New York law, a constructive trust cannot be imposed when the party seeking it is not in
possession of any indicia of ownership. See Bontecou v. Goldman, 477 N.Y.S.2d 192, 194 (App.
Div. 1984) (“Generally, a constructive trust may be imposed when property has been acquired
under such circumstances that the holder of the legal title may not in good conscience retain the
beneficial interest therein.”); cf. A. Brod, 998 F. Supp. at 327–28 (noting, in a case concerning a
motion for summary judgment on a copyright claim, that a constructive trust is only appropriate
if the holder of the property at issue is “not a bona fide purchaser”); Majer v. Schmidt, 564
N.Y.S.2d 722, 725 (App. Div. 1991) (“[I]f a constructive trust is otherwise appropriate, it will be
imposed unless the party who received the property is a bona fide purchaser, i.e., one who took
without notice that it had been wrongfully obtained.” (italics omitted)). Because, by operation of
30
Attachment B, Plaintiff has no remaining ownership interest in the intellectual property at issue,
he cannot seek a constructive trust.
Likewise, “[i]t is well-established under New York law” that, as an equitable remedy,
constructive trusts are inappropriate “where there is an adequate remedy at law,” namely one
under contract law. In re First Cent. Fin. Corp., 377 F.3d 209, 215 (2d Cir. 2004) (internal
quotation marks omitted); see also United States v. Ribadeneira, 920 F. Supp. 553, 556
(S.D.N.Y. 1996) (finding that because the petitioners had “an adequate remedy at law, it would
be inappropriate to afford [them] equitable relief in the form of a constructive trust), aff’d, 105
F.3d 833 (2d Cir. 1997); Cuomo v. Uppal, 892 N.Y.S.2d 49, 50 (App. Div. 2009) (noting that
because the appellant had “adequate legal remedies” it was “not necessary to impose a
constructive trust”); Bertoni v. Catucci, 498 N.Y.S.2d 902, 905 (App. Div. 1986) (“As an
equitable remedy, a constructive trust should not be imposed unless it is demonstrated that a
legal remedy is inadequate.”). While Plaintiff claims that Defendants breached the employment
contract by failing to adequately compensate Plaintiff, Plaintiff does not contest that the
Agreement, as allegedly modified by the Purchase Order, governs his rights to the intellectual
property at issue and any compensation related thereto. (See, e.g., SAC ¶ 238 (arguing that
Plaintiff retains an interest in his intellectual property in proportion to the amount of the
Purchase Order he has not been paid); Pl.’s Aff. ¶ 27 (averring that “[P]laintiff’s signature was
given [on Attachment B] on the sole basis of the promises of payment made to . . . Plaintiff both
in verbal and in writing as embodied in the Purchase Order”).) Therefore, the equitable remedy
of a constructive trust is unavailable. See Islip U-Slip LLC v. Gander Mountain Co., 2 F. Supp.
3d 296, 308 (N.D.N.Y. 2014) (dismissing constructive trust claim because the plaintiff alleged
the existence of a contract and breach of that contract, and did not allege that a “legal remedy—
31
i.e., monetary damages—would be inadequate” (italics omitted)); Abraham v. Am. Home Mortg.
Servicing, Inc., 947 F. Supp. 2d 222, 235 (E.D.N.Y. 2013) (rejecting constructive trust claim
because “[i]t is well established that the existence of a contract precludes a claim for a
constructive trust”). For these reasons, Plaintiff’s constructive trust claim is dismissed.
Sixth, Plaintiff’s wrongful course of dealing claims (claims 21 and 22) are dismissed.
Plaintiff cites N.Y. U.C.C. Law § 1-205(2) (§ 1-303(c)), which describes usage of trade as “any
practice or method of dealing having such regularity . . . as to justify an expectation that it will be
observed with respect to the transaction in question,” in support of these claims.19 However,
Plaintiff fails to allege how usage of trade is relevant to the Agreement. Rather, Plaintiff only
makes conclusory allegations that Defendants “did not follow the [c]ourse of [d]ealing” and that
Defendants Dr. Given and Dr. Zhang “knew [that] Plaintiff’s work and inventions . . . [were]
conceptualized and reduced to practice” before they became involved with their parent projects.
(SAC ¶¶ 212, 217–18.) Even if the Court assumes that Plaintiff intended to cite § 1-205(1)
(§ 1-303(b)), which defines “course of dealing” as “a sequence of conduct concerning previous
transactions between the parties to a particular transaction . . . [that] establish[es] a common
basis of understanding for interpreting their expressions and other conduct,” Plaintiff still fails to
allege how such “course of conduct” was established, how Defendants failed to follow it, how it
trumps the Agreement, and how it would constitute a cause of action. In fact, construing
Plaintiff’s claim liberally, it appears to be a species of Plaintiff’s breach of contract claim, in
which Plaintiff alleges that that he only signed the Agreement on the basis of certain oral
19
Some of the provisions of the N.Y. Uniform Commercial Code that Plaintiff cites have
been reorganized and renumbered. See 2014 N.Y. Sess. Laws ch. 505 (A. 9933) (McKinney).
When applicable, the Court includes parenthetical citations to the current Code for ease of
reference. All quotations are from the current Code.
32
understandings that Defendants have not honored. The Court has, however, already dismissed
this claim.
Plaintiff also cites 35 U.S.C. §§ 116 (inventors) and 118 (filing by other than inventor) in
support of his wrongful course of dealing claims. (See SAC ¶¶ 211, 216.) Plaintiff does not,
however, allege that his intellectual property was “made by two or more persons jointly,” such
that he would be considered an “omitted inventor” under the statute. 35 U.S.C. § 116. Indeed,
because Plaintiff assigned his intellectual property to PepsiCo, § 118 provides that PepsiCo was
permitted to make an application for patent. Cf. Deere, 660 F. Supp. at 436 (noting that, because
the plaintiff could file a patent application as an assignee, there was no need to order the
defendant inventor to sign a declaration indicating there were no bars to the patent applications at
issue). Moreover, as discussed above, 35 U.S.C. § 115 creates “no duty between the patent
applicant and the purported inventor,” but rather “the sole duty created is between the applicant
and the office.” Wise, 769 F.2d at 3; Newberg, 2009 WL 3202380, at *6 (“Under 35 U.S.C.
§ 115 . . . . [t]he duty to disclose all inventors . . . is a duty owed to the USPTO, not to potential
co-inventors. Indeed, a breach of that statutory duty merely results in the patent being
‘unauthorized by law and void.’” (citation omitted) (quoting Wise, 769 F.2d at 3)). Therefore,
Plaintiff’s wrongful course of dealing claims are dismissed.20
20
The Court notes that Plaintiff is correct that, after publication, the USPTO does not
permit a protest of a patent application without the consent of the applicant. See Manual of
Patent Examining Procedure 1901.6(V)(A), U.S. Patent and Trademark Office, available at
http://www.uspto.gov/web/offices/pac/mpep/s1901.html#d0e194658 (last accessed Feb. 18,
2015). (See also Pl.’s Opp’n 10.) However, the fact that Defendants are unlikely to consent to
such a protest does not mean Plaintiff has a cause of action based on the same claim in federal
court.
33
Seventh, Plaintiff’s claim, that PepsiCo “acted in bad faith” in not honoring the Purchase
Order “by subsequently ordering . . . Plaintiff’s name to be expunged from his inventions” and
“by not answering . . . Plaintiff’s request for amendment” (claim 23), is dismissed. (SAC ¶ 223.)
In support of this claim, Plaintiff cites N.Y. U.C.C. Law § 1-203 (§ 1-304), which provides that
“[e]very contract or duty . . . imposes an obligation of good faith in its performance and
enforcement.” However, this statute “does not support an independent cause of action.” Id.
Official Comment; see also J.C. Penny Corp. v. Carousel Ctr. Co., 306 F. Supp. 2d 274, 281
(N.D.N.Y. 2004) (same), aff’d, 160 F.3d 97 (2d Cir. 1998); Grain Traders, Inc. v. Citibank, N.A.,
960 F. Supp. 784, 792 (S.D.N.Y. 1997) (same). Moreover, even if there were a cause of action
under § 1-203 (§ 1-304), Plaintiff fails to allege that PepsiCo was party to a contract that could
have imposed such a duty. As discussed above, the Purchase Order was not a valid modification
to the Agreement, nor was it a contract in its own right, and therefore PepsiCo could not have
acted in bad faith by failing to honor it.21 For these reasons, Plaintiff’s claim that PepsiCo
violated the “[o]bligation [o]f [g]ood [f]aith [a]nd [l]ack [o]f [s]atisfaction” is dismissed.
Eighth and finally, Plaintiff’s negligence claim (claim 27) is dismissed. Plaintiff’s claim
is based solely on the allegation that Defendants’ negligence resulted in their “wrongfully
claim[ing] the ownership and inventorship of . . . Plaintiff’s intellectual property.” (SAC ¶ 251.)
The Court has already found that Defendants’ actions in filing for the patents at issue were not
wrongful. See 35 U.S.C. § 118 (“A person to whom the inventor has assigned . . . the invention
may make an application for patent.”). Moreover, Plaintiff has failed to allege any elements of
the negligence, e.g., a duty and breach thereof, see, e.g., In re MS Angeln GmbH & Co. KG, 10
21
Even if the Purchase Order created a contract between PepsiCo and Plaintiff, the Court
has already found that Plaintiff received what he was promised under that document.
34
F. Supp. 3d 424, 430 (S.D.N.Y. 2014) (noting that the elements of common law negligence are
“duty of care, breach of duty, causation, and damages”), and “[a] contract action cannot be
converted into one arising in tort ‘merely by alleging that the contracting party did not intend to
meet its contractual obligations,’” Aniero Concrete Co. v. N.Y.C. Const. Auth., No. 94-CV-3506,
2000 WL 863208, at *32 (S.D.N.Y. June 27, 2000) (quoting Rocanova v. Equitable Life
Assurance Soc’y of U.S., 634 N.E.2d 940, 944 (N.Y. 1994)). Plaintiff’s negligence claim is
therefore dismissed.
4. Remaining Claims
The dismissal of the above claims notwithstanding, Plaintiff makes additional claims that
pertain to conduct outside the context of the Agreement itself. These claims are equally without
merit.
First, Plaintiff makes a number of claims (claims 15, 16, 17, 18, 19, 20, and 26) based
principally on Article 3 of the New York Uniform Commercial Code, which governs commercial
paper, i.e., negotiable instruments. See N.Y. U.C.C. Law § 3-101; id. cmt. (“This Article
represents a complete revision and modernization of the Uniform Negotiable Instruments
Law.”). Indeed, each of the provisions on which Plaintiff relies refers to negotiable instruments.
See id. §§ 3-105 (conditionality of instruments), 3-303 (taking of instruments for value), 3-304
(notice of claim or defense to instrument), 3-404 (unauthorized signatures on instruments), 3-405
(impostor signatures on instruments), 3-406 (negligence altering instrument), 3-408
(consideration to become a holder in due course of an instrument), 3-507 (dishonored
instrument), 3-603 (payment or satisfaction or an instrument). (See also SAC 33–39, 45–46
35
(citing these provisions).)22 While Plaintiff characterizes Attachment B and the Purchase Order
as commercial paper, (see Pl.’s Opp’n 12), the contracts at issue in this Action are not negotiable
instruments, and therefore the cited provisions of New York law do not apply, see N.Y. U.C.C.
Law § 3-104 (“Any writing to be a negotiable instrument within this Article must [be] . . . . .(a) a
‘draft’ (‘bill of exchange’) if it is an order; (b) a ‘check’ if it is a draft drawn on a bank and
payable on demand; (c) a ‘certificate of deposit’ if it is an acknowledgment by a bank of a receipt
of money with an engagement to repay it; (d) a ‘note’ if it is a promise other than a certificate of
deposit”); Stroll v. Epstein, 818 F. Supp. 640, 643 n.4 (S.D.N.Y. 1993) (“[T]he present contract
is not a negotiable instrument because it is not payable to order or to bearer.” (internal quotation
marks omitted) (citing N.Y. U.C.C. Law § 3-104)); President, etc. of Manhattan Co. v. Morgan,
210 N.Y.S. 460, 462 (App. Div. 1925) (“Written contracts are not negotiable, because by their
terms, they are payable or insure to the benefit of the bearer.”), aff’d, 150 N.E. 594 (N.Y. 1926).
Likewise, the Purchase Order is not a negotiable instrument because it is signed by neither the
alleged maker, PepsiCo, nor the alleged drawer, Plaintiff. See N.Y. U.C.C. Law § 3-104
(providing that to be “a negotiable instrument,” a writing must “be signed by the maker or
drawer”). Therefore, these claims are dismissed as without merit because they have no basis in
law, nor any application to this case.23
22
Claim 17 also makes reference to N.Y. U.C.C. Law § 1-201(32) (§ 1-201(b)(29)),
which defines “Purchase.” Though Plaintiff cites this provision as proof of the meaning of
“purchase order,” (see, e.g., Dkt. No. 47 at 1), the provision has no relevance to the claims at
issue in this case.
Moreover, insofar as Plaintiff alleges that “[o]nly the inventor can authorize a patent
application to be made,” this claim, as discussed above, is contradicted by 35 U.S.C. § 118,
which provides that the assignee of an invention may file for a patent application, and contains
no provision requiring authorization by the inventor.
23
36
Second, Plaintiff alleges “[r]acism, [r]acial [d]iscrimination, [h]umiliation, [i]nsults [a]nd
[d]enigration” (claim 28). (SAC 47.) Plaintiff’s support for this claim is (a) his allegation that
PepsiCo’s Vice President for Research and Development, Valerie Jacklin, sent an email to Dr.
Given and the Director of the Ingredient Technology group indicating that she was “not sure
[they] want[ed] [Plaintiff] [o]n [t]he [i]nvention [l]ist,” and that this was because of unspecified
“stereotypes and racial clichés about . . . Plaintiff as a person of . . . black skin;” (b) Plaintiff’s
allegation that Defendants articulated this position to the U.S. government, together with the
“representation that . . . Plaintiff was not able to do any work and . . . went to work only to look
for opportunities for predatory sexual intercourse activity on women;” and (c) Plaintiff’s
allegation that he was told by an unnamed human resources manager that he was “‘culturally
unfit’” for employment because he was “a black male [with] an opinion on scientific matters that
was contrary to that of his peers of [another] skin color.” (Id. ¶¶ 65, 255, 257–58 (italics
omitted).)24 While Defendants’ conduct, if truthfully alleged, would be reprehensible, it is
nonetheless facially insufficient to state a claim. Plaintiff does not allege what law, state or
federal, Defendants have violated. Moreover, the claim lacks specific factual allegations, and
instead rests on the conclusory allegation that Defendants’ actions, both in taking credit for
Plaintiff’s inventions and terminating his employment, were motivated by racial animus. Such
allegation fails to state a claim for racial discrimination. See Phifer ex rel. Phifer v. City of New
York, No. 99-CV-4422, 2003 WL 1878418, at *6 (S.D.N.Y. Apr. 15, 2003) (dismissing racial
discrimination claim because, inter alia, “[t]he complaint sets forth only conclusory assertions . .
Plaintiff also alleges that Defendants’ “legal counsel made comments in the presence
of Plaintiff that ‘justice . . . is . . . a hater of the black people aka nigga behind closed doors.’”
(SAC ¶ 261 (alterations in original) (italics omitted).) Additionally, in his Affidavit, Plaintiff
names a PepsiCo employee that he alleges PepsiCo thought was a target of his sexual advances.
(See Pl.’s Aff. ¶ 114.)
24
37
. and fails to specifically allege the circumstances giving rise to a plausible inference of racially
discriminatory intent" (internal quotation marks omitted)); cf Iqbal, 556 U.S. at 663 (" [T]he
tenet that a court must accept a complaint ' s allegations as true is inapplicable to threadbare
recitals of the elements of a cause of action, supported by mere conclusory statements");
Schwapp v. To wn of Avon, 118 F.3d 106, 111 (2d Cir. 1997) (affirming the district court' s
rejection of affidavits that made only "bald assertions and legal conclusions" of " racism and a
racially hostile working environment"). Plaintiff's racism-based claim is therefore dismissed
because the allegations are "simply too thin and conclusory to support a facially plausible
claim." Doner-Hendrick v. N. Y Inst. ofTech. , No . 11-CV-121, 2011 WL 2652460, at *7
(S.D.N.Y. Jul y 6, 2011 ).
III. CONCLUSION
For the foregoing reasons, Defendants' Motion To Dismiss is granted . Plaintiff's First
Amended Complaint is dismissed without prejudice. Plaintiff may fil e a Second Amended
Complaint within thirty days that specifically addresses the deficiencies identified in this
Opinion. Also , Plaintiff may renew his request to join Scentsational Technologies LLC and
Steven M. Landau and fil e claims against them . The Clerk of the Court is respectfully requested
to terminate the pending Motion (Dkt. No . 34).
SO ORDERED.
DATED:
March _]___, 2015
White Plains, New York
38
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?